Figure 2From: TP53 status and taxane-platinum versus platinum-based therapy in ovarian cancer patients: A non-randomized retrospective studyKaplan-Meier curves for overall survival in the TP53(-) group in patients at the age of 53 years (median) or younger.Back to article page